Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-014932·1Globe Capital LLC
Schedule 13G ownership disclosure
CRESCENT BIOPHARMA INC.
Ordinary Shares, par value $0.001 per share · CUSIP: 38000Q201
Event date: 2025-10-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 1Globe Capital LLC
Shares: 1,425,432.00 · Class: 10.3%
- Jiaqiang Li
Shares: 1,425,432.00 · Class: 10.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-014932
- Form type
- SCHEDULE 13G/A
- Filer
- 1Globe Capital LLC
- CIK
- CIK 1562189
- Filed
- Oct 14, 2025
- Reporting period
- Oct 07, 2025
- Description
- Schedule 13G beneficial ownership